Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
7.04
-0.20 (-2.76%)
At close: Nov 20, 2026, 4:00 PM EST
7.03
-0.01 (-0.14%)
After-hours: Nov 20, 2026, 7:30 PM EST
Evommune Revenue
In the year 2025, Evommune had annual revenue of $13.00M with 85.71% growth. That makes Evommune the 37,412th largest company in the world by revenue and 4,896th in the United States.
Revenue (ttm)
$13.00M
Revenue Growth
+85.71%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
291.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.00M | 6.00M | 85.71% |
| Dec 31, 2024 | 7.00M | 2.00M | 40.00% |
| Dec 31, 2023 | 5.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
EVMN News
- 3 days ago - Evommune Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - Evommune price target lowered to $23 from $26 at Morgan Stanley - TheFly
- 9 days ago - Evommune reports Q3 EPS (85c), consensus (86c) - TheFly
- 9 days ago - Evommune Reports Third Quarter 2026 Financial Results and Provides Business Highlights - Business Wire
- 9 days ago - Evommune Earnings release: Q3 2026 - Filings
- 9 days ago - Evommune Quarterly report: Q3 2026 - Filings
- 9 days ago - Evommune Slides: Corporate presentation - Filings
- 10 days ago - Evommune Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts